• Home
  • Login
  • Contact

Pharmacists and the Heart, 2018 ACCP International Symposium

Posted

Pharmacists and the Heart: Advancing Care for Patients with Cardiovascular Disease

Held in Conjunction with the 26th Order of Pharmacists of Lebanon Annual Congress

Target Audience

The symposium is designed for pharmacists and pharmacy trainees caring for patients with cardiovascular diseases in all practice settings.

Symposium Goal

The symposium will discuss recent updates to guidelines for the management of common chronic and acute cardiovascular diseases and analyze findings from key practice-changing clinical trials that advance healthcare. Sessions will employ case-based learning to engage participants in activities that enable them to translate published evidence into daily practice and improve outcomes associated with patient care services.

At the conclusion of the symposium, the participant should be able to:

  1. Apply current guidelines and recent clinical trial evidence for managing hypertension, dyslipidemia, and heart failure.
  2. Provide evidence-based, individualized recommendations for therapy with antithrombotic agents.
  3. Recommend optimal strategies for the pharmacological management of patients presenting with acute coronary syndrome.
  4. Devise outcome measures to assess, document, and advance the quality and cost-effectiveness of patient care services provided by pharmacists.

Agenda

8:45 a.m.

Welcome and Introductions

9:00 a.m.

Clinical Guidelines: Updates in Hypertension, Dyslipidemia, and Heart Failure

11:00 a.m.

Coffee Break

11:30 a.m.

Antithrombotic Agents: Clinical Evidence and Agent Selection Lunch

3:00 p.m.

Acute Coronary Syndrome: Optimal Pharmacotherapy Strategies

4:30 p.m.

Coffee Break

5:00 p.m.

Measuring Outcomes Associated with Pharmacist Services

5:30 p.m.

Closing Remarks

Session Learning Objectives

Clinical Guidelines: Updates in Hypertension, Dyslipidemia, and Heart Failure

At the conclusion of the session, the participant should be able to:

  1. Develop a guideline-based treatment plan for patients with hypertension, dyslipidemia, and heart failure.
  2. Recognize the limitations of recent trials in patients with hypertension, dyslipidemia, and heart failure in developing individualized treatment plans.
  3. Devise suitable monitoring plans to ensure safe use of medications in patients with hypertension, dyslipidemia, and heart failure.


Antithrombotic Agents: Clinical Evidence and Agent Selection

At the conclusion of the session, the participant should be able to:

  1. Differentiate between common chronic antithrombotic agents used in the management of patients with atrial fibrillation, and patients with ischemic heart disease.
  2. Recommend an individualized treatment plan to reduce stroke in patients with atrial fibrillation.
  3. Determine a suitable antithrombotic regimen for patients with stable ischemic heart disease.


Acute Coronary Syndrome: Optimal Pharmacotherapy Strategies

At the conclusion of the session, the participant should be able to:

  1. Develop an acute treatment plan for a patient presenting with acute coronary syndromes.
  2. Choose a suitable antithrombotic regimen for patients with acute coronary syndromes.
  3. Create a secondary prevention plan after an acute coronary syndrome.


Measuring Outcomes Associated with Pharmacist Services

At the conclusion of the session, the participant should be able to:

  1. Ascertain target cardiac conditions which may benefit from pharmacist services.
  2. Identify potential measures for examining pharmacist services in cardiology.
  3. Develop an outline for a program to measure the quality of outcomes associated with pharmacist services in cardiology.

Symposium Moderator

Wafa Y. Dahdal, Pharm.D.
Director of International Programs &
Associate Director of Professional Development
American College of Clinical Pharmacy

Program Faculty

Dr. Cynthia Jackevicius

Cynthia Jackevicius, BScPhm, PharmD, MSc, APh, BCPS-AQ Cardiology, FCSHP, FAHA, FCCP, FCCS
Professor & Director, Cardiovascular Outcomes Research Fellowship, College of Pharmacy, Western University of Health Sciences
Clinical Pharmacy Specialist, Cardiology, VA Greater Los Angeles Healthcare System
Senior Adjunct Scientist, Institute for Clinical Evaluative Sciences
Associate Professor, Institute for Health Policy, Management & Evaluation, University of Toronto

Faculty Disclosures

Dr. Dahdal and Dr. Jackevicius have no relevant affiliations or financial relationships with commercial interest to disclose.

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).

ACCP designates this activity for 6.0 CPE hours. Partial credit is not available.

Type of Activity: Application-based

Universal Activity Number: 0217-0000-18-238-L01-P

Expiration Date: December 17, 2018

To earn CPE credit for this activity, the participant must attend all 6.0 contact hours of programming, complete the associated evaluation, and claim credit at www.accp.com/ce by December 17, 2018.

To obtain a statement of credit for this activity, international participants must update their ACCP profile at www.accp.com/myaccount/licensure.aspx by checking the box “I am an international pharmacist, and do not have an NABP e-Profile ID.” Participants with an NABP e-Profile ID on file with ACCP will obtain their statement of credit from www.mycpemonitor.net.

Certificates of Attendance

Certificates of attendance will be granted to participants attending the entire symposium.

Commerical Support

No commercial support has been received for this activity.

Registration

Travel and Accommodations

Information on travel and accommodations is available here.

 

Questions:Contact IntlClinPharmacist@accp.com

Dedicated to Excellence in Clinical Pharmacy Practice, Research, and Education

Unsubscribe at http://www.accp.com/myaccount/settings.aspx?i=1987197&e=rony_zeenny@hotmail.com.
The American College of Clinical Pharmacy - 13000 W. 87th Street Pkwy, Suite 100, Lenexa, KS 66215 - (913) 492-3311

 


Pharmacists and the Heart, 2018 ACCP International Symposium

Posted

Pharmacists and the Heart: Advancing Care for Patients with Cardiovascular Disease

Held in Conjunction with the 26th Order of Pharmacists of Lebanon Annual Congress

Target Audience

The symposium is designed for pharmacists and pharmacy trainees caring for patients with cardiovascular diseases in all practice settings.

Symposium Goal

The symposium will discuss recent updates to guidelines for the management of common chronic and acute cardiovascular diseases and analyze findings from key practice-changing clinical trials that advance healthcare. Sessions will employ case-based learning to engage participants in activities that enable them to translate published evidence into daily practice and improve outcomes associated with patient care services.

At the conclusion of the symposium, the participant should be able to:

  1. Apply current guidelines and recent clinical trial evidence for managing hypertension, dyslipidemia, and heart failure.
  2. Provide evidence-based, individualized recommendations for therapy with antithrombotic agents.
  3. Recommend optimal strategies for the pharmacological management of patients presenting with acute coronary syndrome.
  4. Devise outcome measures to assess, document, and advance the quality and cost-effectiveness of patient care services provided by pharmacists.

Agenda

8:45 a.m.

Welcome and Introductions

9:00 a.m.

Clinical Guidelines: Updates in Hypertension, Dyslipidemia, and Heart Failure

11:00 a.m.

Coffee Break

11:30 a.m.

Antithrombotic Agents: Clinical Evidence and Agent Selection Lunch

3:00 p.m.

Acute Coronary Syndrome: Optimal Pharmacotherapy Strategies

4:30 p.m.

Coffee Break

5:00 p.m.

Measuring Outcomes Associated with Pharmacist Services

5:30 p.m.

Closing Remarks

Session Learning Objectives

Clinical Guidelines: Updates in Hypertension, Dyslipidemia, and Heart Failure

At the conclusion of the session, the participant should be able to:

  1. Develop a guideline-based treatment plan for patients with hypertension, dyslipidemia, and heart failure.
  2. Recognize the limitations of recent trials in patients with hypertension, dyslipidemia, and heart failure in developing individualized treatment plans.
  3. Devise suitable monitoring plans to ensure safe use of medications in patients with hypertension, dyslipidemia, and heart failure.


Antithrombotic Agents: Clinical Evidence and Agent Selection

At the conclusion of the session, the participant should be able to:

  1. Differentiate between common chronic antithrombotic agents used in the management of patients with atrial fibrillation, and patients with ischemic heart disease.
  2. Recommend an individualized treatment plan to reduce stroke in patients with atrial fibrillation.
  3. Determine a suitable antithrombotic regimen for patients with stable ischemic heart disease.


Acute Coronary Syndrome: Optimal Pharmacotherapy Strategies

At the conclusion of the session, the participant should be able to:

  1. Develop an acute treatment plan for a patient presenting with acute coronary syndromes.
  2. Choose a suitable antithrombotic regimen for patients with acute coronary syndromes.
  3. Create a secondary prevention plan after an acute coronary syndrome.


Measuring Outcomes Associated with Pharmacist Services

At the conclusion of the session, the participant should be able to:

  1. Ascertain target cardiac conditions which may benefit from pharmacist services.
  2. Identify potential measures for examining pharmacist services in cardiology.
  3. Develop an outline for a program to measure the quality of outcomes associated with pharmacist services in cardiology.

Symposium Moderator

Wafa Y. Dahdal, Pharm.D.
Director of International Programs &
Associate Director of Professional Development
American College of Clinical Pharmacy

Program Faculty

Dr. Cynthia Jackevicius

Cynthia Jackevicius, BScPhm, PharmD, MSc, APh, BCPS-AQ Cardiology, FCSHP, FAHA, FCCP, FCCS
Professor & Director, Cardiovascular Outcomes Research Fellowship, College of Pharmacy, Western University of Health Sciences
Clinical Pharmacy Specialist, Cardiology, VA Greater Los Angeles Healthcare System
Senior Adjunct Scientist, Institute for Clinical Evaluative Sciences
Associate Professor, Institute for Health Policy, Management & Evaluation, University of Toronto

Faculty Disclosures

Dr. Dahdal and Dr. Jackevicius have no relevant affiliations or financial relationships with commercial interest to disclose.

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).

ACCP designates this activity for 6.0 CPE hours. Partial credit is not available.

Type of Activity: Application-based

Universal Activity Number: 0217-0000-18-238-L01-P

Expiration Date: December 17, 2018

To earn CPE credit for this activity, the participant must attend all 6.0 contact hours of programming, complete the associated evaluation, and claim credit at www.accp.com/ce by December 17, 2018.

To obtain a statement of credit for this activity, international participants must update their ACCP profile at www.accp.com/myaccount/licensure.aspx by checking the box “I am an international pharmacist, and do not have an NABP e-Profile ID.” Participants with an NABP e-Profile ID on file with ACCP will obtain their statement of credit from www.mycpemonitor.net.

Certificates of Attendance

Certificates of attendance will be granted to participants attending the entire symposium.

Commerical Support

No commercial support has been received for this activity.

Registration

Travel and Accommodations

Information on travel and accommodations is available here.

 

Questions:Contact IntlClinPharmacist@accp.com

Dedicated to Excellence in Clinical Pharmacy Practice, Research, and Education

Unsubscribe at http://www.accp.com/myaccount/settings.aspx?i=1987197&e=rony_zeenny@hotmail.com.
The American College of Clinical Pharmacy - 13000 W. 87th Street Pkwy, Suite 100, Lenexa, KS 66215 - (913) 492-3311

 


©2016 Copyright  ORDER OF PHARMACISTS OF LEBANON All Rights Reserved. SITEMANAGERV2.3